Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others ...

(RTTNews) - British drug maker GSK plc (GSK.L, GSK) Monday announced that it has signed an agreement to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company, for up to $1.15 billion ...

Dr. Ngozi Ezike, the face of Illinois' response to the COVID-19 pandemic, admitted to an ethics violation for taking the CEO ...

The first major deal of JPM 2025 will give GSK a promising small molecule drug for gastrointestinal stromal tumors.

To address this, Science X is excited to introduce a new feature: The GIST—short for "Get Instant Summarized Text." The GIST provides concise, AI-generated summaries of each article, offering readers ...

British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specialises in the treatment of rare gastrointestinal cancer GIST.

These data continue to demonstrate promising anti-tumor activity of IDRX-42 in patients with advanced GIST and will be highlighted today in an oral presentation at the Connective Tissue Oncology ...

The greater part of the pamphlet, in which he ratiocinatively explains the gist of all philosophy to be its own insufficiency to comprehend or in any way state the All, is marked by acuteness of ...

Gist (6-0, 197) is currently ranked a three-star, the No. 2,029 overall recruit in the 2025 On3 Industry Rankings. He is also ranked the No. 146 running back and the No. 55 recruit in Illinois.

UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company ...